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Abstract
Background: Knee osteoarthritis is a major cause of pain and functional limitation. Complementary and alternative 
medical approaches have been employed to relieve symptoms and to avoid the side effects of conventional 
medication. Moxibustion has been widely used to treat patients with knee osteoarthritis. Our past researches 
suggested heat-sensitive moxibustion might be superior to the conventional moxibustion. Our objective is to 
investigate the effectiveness of heat-sensitive moxibustion compared with conventional moxibustion or conventional 
drug treatment.
Methods: This study consists of a multi-centre (four centers in China), randomised, controlled trial with three parallel 
arms (A: heat-sensitive moxibustion; B: conventional moxibustion; C: conventional drug group). The moxibustion 
locations are different from A and B. Group A selects heat-sensitization acupoint from the region consisting of Yin 
Lingquan(SP9), Yang Lingquan(GB34), Liang Qiu(ST34), and Xue Hai (SP10). Meanwhile, fixed acupoints are used in 
group B, that is Xi Yan (EX-LE5) and He Ding (EX-LE2). The conventional drug group treats with intra-articular Sodium 
Hyaluronate injection. The outcome measures above will be assessed before the treatment, the 30 days of the last 
moxibustion session and 6 months after the last moxibustion session.
Discussion: This trial will utilize high quality trial methodologies in accordance with CONSORT guidelines. It will 
provide evidence for the effectiveness of moxibustion as a treatment for moderate and severe knee osteoarthritis. 
Moreover, the result will clarify the rules of heat-sensitive moxibustion location to improve the therapeutic effect with 
suspended moxibustion, and propose a new concept and a new theory of moxibustion to guide clinical practices.
Trial Registration: The trial is registered at Controlled Clinical Trials: ChiCTR-TRC-00000600.
Background
Osteoarthritis (OA) is the most common form of arthritis
[1] and the leading cause of disability among older adults
[2,3]. As one part of weight-bearing peripheral and axial
joints, knee is the most commonly affected by osteoar-
thritis [4]. Among adults aged 30 years, symptomatic
knee OA occurs in 6% and symptomatic hip OA in about
3%[4].Knee osteoarthritis (KOA) is associated with symp-
toms of pain and functional disability. Physical disability
arising from pain and loss of functional capacity reduces
the quality of life and increases the risk of further mor-
bidity and mortality [5]. The prevalence, disability, and
associated costs of KOA are expected to steadily increase
over the next 25 years because of aging in the population
[6]. After adjusting for age, sex, and comorbidity, KOA is
responsible for a higher percentage of disability than any
other medical condition for the following activities: stair
climbing, walking a mile, and housekeeping.
The underlying disease processes of KOA involve carti-
lage degeneration, proliferation and remodeling of sub-
chondral bone structure. Recently there is no cure for
KOA [7]. Therefore, the treatment of KOA is primarily
focused on managing the condition by minimizing mor-
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bidity. The current conventional treatment of KOA
symptoms and analgesics, such as NSAIDS, glucosamine,
topical analgesics, intra-articular (Sodium Hyaluronate,
Synvisc) and surgical treatment[8,9]. Substantial numbers
of patients with KOA are not satisfied with conventional
drug treatment and repeatedly experience side effects
[10,11]. As a result, a large number of patients with KOA
are turning to complementary and alternative treatments.
Non-pharmacological treatments such as acupuncture
are therefore attractive. Acupuncture is often used for
KOA. For example, it is gaining popularity among KOA
patients in the US and about 1 million consumers utilize
acupuncture annually which has musculoskeletal disor-
ders [12].
Acupuncture is a safe treatment that has a low risk for
serious side effects. Moxibustion is a traditional Chinese
method of acupuncture treatment, which utilizes the heat
generated by burning Moxa (it is also called Mugwort or
Moxa) to stimulate the acupuncture points. The tech-
nique consists of lighting a moxa stick and bringing it
close to the skin until it produces hyperaemia due to local
vasodilatation. The intensity of moxibustion is just below
the individual tolerability threshold. Moxibustion has
anti-inflammatory or immunomodulatory effects against
chronic inflammatory conditions in humans [13]. More-
over, the heat of moxa treatment improves microcircula-
tion in the knee. Therefore, these Arthritis substances
may be reduced and weakened by moxibustion. Then
Elimination of swelling and pain relief also may be
achieved. Especially for swell type KOA, which derived
from surrounding tissues strain, moxibustion may get a
better effect. Further deterioration of cartilage is set back,
as a result of pathological chain of KOA is cut in treat-
ment of moxibustion. That is to say, moxibustion does
not make osteophyte disappeared in short treatment, but
its therapeutic effects relieve the main symptoms, and
minimizing morbidity of new osteophyte by avoiding
pathological product of stimulus and mechanical struc-
tural imbalance.
Although firm evidence has not been established, the
results of some systematic review and meta-analysis sug-
gest that acupuncture and moxibustion may effective in
the treatment of KOA [14-16].Such as the latest meta-
analysis concluded that sham-controlled trials showed
clinically irrelevant short-term benefits of acupuncture
for treating knee osteoarthritis. Waiting list controlled
trials suggested clinically relevant benefits, some of which
may be due to placebo or expectation effects [16]. How-
ever, these reviews do not confirm the efficacy of acu-
puncture and moxibustion. This may be because all
relevant RCTs were limited by methodological defects,
including inappropriate sample size, variability of acu-
puncture and sham protocols, and missing information.
Therefore, rigorous high-quality randomised controlled
trials are needed.
Thinking about moxibustion itself, the selection of
location for manipulating Moxa plays an important role
in obtaining good effects [17]. In our opinion, the nature
of acupoint is not location , but status. In the human
being there are two functional states, sensitization state
and rest state. When the human body has disease, acu-
points on the body surface may be sensitized with various
types of sensitization, and acupoint heat-sensitization is a
type of acupoint sensitization. The sensitized acupoints
show acupoint-specific "small stimulation inducing large
response" for external relative stimulation. The Inner
Canon of Huangdi or Yellow Emperor's Inner Canon is an
ancient Chinese medical text that has been treated as the
fundamental doctrinal source for Chinese medicine for
more than two millennia and until today. According with
its core viewpoint and theory, acupoint is described and
understood with the state , which is certain area of the
skin in the course of diseases. Among the changes, sensi-
tized status is the common one, described that acupoints
on the body surface may be sensitized with various types
of sensitization. This sensitized acupoint is not only the
pathological phenomenon reflecting the diseases but also
stimulating location with acupuncture and moxibustion.
Acupoint heat-sensitization is a type of acupoint sensiti-
zation.
Our research term found that the heat-sensitized phe-
nomenon was a new type of acupoint sensitized features
in pathological state [18-20]. We applicated the acupoint
heat-sensitization phenomenon and rule in the past
twenty years. The past experiential evidences in our
research indicated that the functional state might jump
from the rest state to the heat-sensitized state suffering
from diseases. Its characteristic was thought that these
special acupoints might produce heat response and far-
ther warm sensation, as a result of stimulation of moxi-
bustion heat. If we can search out these heat-sensitized
acupoints associating with pathological state, good effect
will be achieved. Therefore, selecting the heat-sensitized
acupoint may obtain therapeutic effect far better than
acupuncture and moxibustion at acupoints of routine rest
state. We carried our many clinical trials to test and verify
the efficacy heat-sensitized acupoint, such as myofascial
pain syndrome [21], lumbar disc herniation[22], pressure
sores[23] and KOA[24]. The result of clinical trials almost
suggested superiority effect of heat-sensitized acupoint
and encouraged us to proceed.
With these constraints, we planned a rigorous multi-
centre randomised controlled trial with a large sample
size.Chen et al. BMC Complementary and Alternative Medicine 2010, 10:32
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Method/design
Objective
The aim of this study is to investigate the effectiveness of
heat-sensitive moxibustion compared with conventional
moxibustion or conventional drug treatment (intra-artic-
ular Sodium Hyaluronate injection) in patients with mod-
erate to severe KOA in China.
Outcome
Ministry of Health of the People's Republic of China
( M H P R C )  h a s  p r o p o s e d  a  s e r i e s  o f  c r i t e r i a  t o  d e f i n e
patient response in the context of clinical trials of KOA,
known as the guiding principle of clinical research on
new drugs (GPCRND) [25]. According to these criteria, a
patient with KOA is assessed including pain, the relation
between activity and pain, function impairment, and spe-
cial exams (Table 1). This scoring system was previously
validated. The degree of KOA is divided into three level:
mild- < 5 score;moderate-5 ~ 9 score; severe-> 9 score.
Therapeutic effect was assessed by comparing baseline
and final conditions reported by the patient. Four catego-
ries were listed as below: clinical response-no symptom,
normal function activity, clinical symptom score reduc-
tion ≥ 95%; markedly effective-no obvious symptom, nor-
mal joint function activity, able to participate in activity
and work, clinical symptom score reduction 70 ~ 95%;
improved-no pain, normal joints' flexion and extension,
improvement in activity and work, clinical symptom
score reduction 30 ~ 70%; ineffective-not arrived at the
above standard involving with symptom and function
impairment, clinical symptom score reduction < 30%.
This trial also records adverse effects reported by
patients during treatment. The outcome measures above
will be assessed before the treatment, the 30 days of the
last moxibustion session and 6 months after the last mox-
ibustion session.
Design
A multi-centre (four centers in China), randomised, sub-
ject blinded(group A and B) and assessor blinded, posi-
tive controlled trial will be conducted at the Jiangxi
Traditional Chinese Medicine Hospital in Nanchang, The
first Affiliated Hospital with Anhui University of TCM in
Hefei, Jiangsu Traditional Chinese Medicine Hospital in
Nanjing, and Shanxi Traditional Chinese Medicine Hos-
pital in Xian. The study will be sequentially conducted as
follows: a run-in period of one week prior to randomisa-
tion, a treatment period of 30 days (5 sessions per week),
and a follow-up period of six months. The total study
period will be eight months. At the end of the run-in
period, participants will be randomised to the heat-sensi-
tive moxibustion group, the conventional moxibustion
group, or the conventional drug treatment group by the
central randomization system (Figure 1).This system is
provided by China Academy of Chinese Medical Sci-
ences, which adopted the computer telephone integration
(CTI) technology to integrate computer, internet and
telecom. The random number list will be assign by inter-
active voice response (IVR) and interactive web response
(IWR)[26]. The success of blinding will be assessed at
each participant's last visit. Researchers who did not par-
ticipate in the treatment and who are blinded to the allo-
cation results will perform the outcome assessment
Eligibility
Inclusion criteria
Eligible participants will be those previously diagnosed
with moderate to severe KOA, according to the
GPCRND-KOA criteria(> 5 score). Patients will be
required to complete the baseline KOA diary. Written
informed consent will be obtained from each participant.
, Participants 38 ~ 70 years of age will be recruited from
outpatient and inpatient in four centers. Standard of diag-
nosis listed as follows:(1) Keen pain almost occurred in
the past one month; (2)Osteophyma at the edge of joints
are all well demonstrated in X-ray; (3)Laboratory exami-
nations of arthritis support the diagnosis of osteoarthri-
tis;(4) Morning stiffness continued less than 30
minutes;(5) Bone sound existed when joints was taking
flexion and/or extension. If a patient accord with (1), (2),
or (1), (3), (4), (5), we can diagnose. Since the research
involves moderate to severe KOA or severe KOA, the
inclusion criteria will restrict the following conditions:
According with the below KOA diagnosis standard,
meanwhile, knee joints appear die Schwellung; Floating
patella test is negative; Patients accept the treatment pro-
tocol in this trial; Acupoint heat-sensitization phenome-
non exists in the region consisting of Yin Lingquan(SP9),
Yang Lingquan(GB34), Liang Qiu(ST34), and Xue Hai
(SP10).
Participants will be instructed to stop KOA symptom-
atic relief medication during the run-in and treatment
periods and will be provided the usual care instruction
for KOA.
Exclusion criteria
Participants will be excluded if they suffer from serious
life-threatening disease, such as disease of the heart and
brain blood vessels, liver, kidney and hematopoietic sys-
tem, and psychotic patients. Participants will not be eligi-
ble if the female are in the duration of pregnancy or
lactation. The following conditions are also excluded
items: acute knee joint trauma or ulceration in its local
skin; complicated with serious genu varus/valgue and
flexion conttration.Chen et al. BMC Complementary and Alternative Medicine 2010, 10:32
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Treatment protocol
Heat-sensitive moxibustion
Moxibustion will be performed by certified acupuncture
medical doctors at four centers. Qualified specialists of
acupuncture in traditional Chinese medicine with at least
five years of clinical experience will perform the acupunc-
ture in this study . All treatment regimens will be stan-
dardized between four centers practitioners via video,
hands-on training and internet workshops. Participants
will be randomly assigned to the heat-sensitive moxibus-
tion group, the conventional moxibustion group, or the
conventional drug group. In the former groups, a 22 mm
(diameter) × 160mm (length) moxa-sticks (Jiangxi Tradi-
tional Chinese Medicine Hospital, China) will be used.
The patient is usually in the comfortable supine position
for treatment, with 24°C ~ 30°C temperature in the room.
He should be wearing loose trousers, especially making
his knee joints exposed.
For the heat-sensitive moxibustion group, the moxa-
sticks are lit by the therapist and held over the region
Table 1: List of GPCRND-KOA
Item Grade/Classification Score
Pain or discomfort in night when lying in 
bed
No 0
Pain in activity or some position 1
Pain in non-activity 2
Morning stiffness or pain worse when 
getting out of bed
No 0
< 30 minutes 1
≥ 30 minutes 2
Pain or discomfort in walk No 0
After walking in some distance 1
Pain at beginning of walk or worse 2
Arise from seat Independent 0
Need assistance 1
The maximum walk distance(accompany 
with pain)
Unrestricted 0
Restricted, > 1 km 1
300 m ~ 1 km 2
< 300 m 3












Walk over rough terrain
Independent 0
Difficulty 1
Unable 2Chen et al. BMC Complementary and Alternative Medicine 2010, 10:32
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Figure 1 The flow diagram is intended to depict the passage of participants through this RCT.Chen et al. BMC Complementary and Alternative Medicine 2010, 10:32
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consisting of Yin Lingquan(SP9), Yang Lingquan(GB34),
Liang Qiu(ST34), and Xue Hai (SP10). The warming sus-
pended moxibustion about distance of 3cm are used to
search the acupoint heat-sensitization phenomenon. The
following patients sensation will suggest the special heat-
sensitization aupoint: diathermanous sensation due to
moxa-heat, defining as the heat sensation conducting
from the moxa local skin surface into deep tissue, or even
into the joint cavity; expand heat sensation due to moxa-
heat, defining as the heat sensation spreading the sur-
rounding little by little around the moxa point; transfer
heat sensation due to moxa-heat, defining as the heat
sensation transferring along some pathway or direction,
even to the ankle or hip conduction; non-heat sensation
due to moxa-heat. When some acupoint exists one below
sensation at least, the therapists mark the point as heat-
sensitive acupoint. We try our best to seek all the special
acupoints in each patient by the repeated manipulation.
The therapists begin to treat patients from the most
heat-sensitive intensity acupoint. Treatment sessions end
when patients are feel the acupoint heat-sensitization
phenomenon disappeared. Generally speaking, we find
the time range from 30 ~ 60 minutes.Patients receive the
treatment two times/day in 1st week(two times/day from
2nd week ) for a total of 35 sessions over 30 days.
Conventional moxibustion group
Patients assigning in conventional moxibustion group
will receive fixed acupoint moxibustion. Common prac-
tices are similar with the first group. The different manip-
ulation is that the therapists carry out warming
moxibustion in traditional acupoint, selecting Xi Yan
(EX-LE5) and He Ding (EX-LE2). One point is treated
15minutes a time. Three points are treated by suspended
moxibustion at the same time. In the treatment, the ther-
apists make patients the same intensity of local warm
sensation as the former group. The sensation of acupoint
heat-sensitization phenomenon is not pursued and not
avoided in the treatment. Patients receive the treatment
two times/day in 1st week (two times/day from 2nd week)
for a total of 35 sessions over 30 days.
Conventional drug group
Now, intra-articular hyaluronan (HA) or hylan is popular
approved for the treatment of KOA [27]. A number of
systematic reviews have published positive evidence of
efficacy and safety of intra-articular HA for KOA. For
example, a recent review proved HA to be an effective,
safe, and tolerable treatment for symptomatic KOA [28].
Therefore, this protocol selected Sodium Hyaluronate
Injection Intra-articula as the conventional drug. The




We will conduct analysis on an intention-to-treat basis
(significance level p < 0.05) using the SAS statistical pack-
age program (ver. 9.1.3).The analysis of center effect will
be used Cochran-Mantel-Haenszel. Baseline characteris-
tics will be shown as mean ± standard deviation (SD) for
continuous data including age, previous duration, and
GPCRND-KOA criteria. As for participants' gender, n (%)
of male and female in each group will be shown as base-
line characteristics. We will conduct between-group
comparision in baseline using ANCOVA (analysis of
covariance) for continuous data and using Chi-square
test or nonparametric test for gender composition con-
sidering p < 0.05 as statistically significant.
For outcome measures, the mean differences from
baseline values to the end of treatment will be compared
using ANCOVA. If any imbalances in baseline character-
istics between groups are encountered, we will conduct
ANCOVA (analysis of covariance) using these imbal-
anced variables as covariates and allocated group as fixed
factor.
Data integrity
The integrity of trial data will be monitored by regularly
scrutinizing data sheets for omissions and errors. Data
will be double-entered and the source of any inconsisten-
cies will be explored and resolved.
Sample size
We wished to estimate the sample size that would suffice
to detect GPCRND-KOA between the heat-sensitive and
conventional moxibustion groups. In our previous pilot
study, the effective rate in heat-sensitive moxibustion
group is 70%, and 50% in the other group. If we apply a
two-sided 5% significance level, 95% power the calculated
required sample size is approximately 120 participants in
each group, according to the following equation. Allow-
ing for a 20% loss to follow up, a total of 144 participants
will be required in each group, with 432 participants in
total.
Adverse events
We define adverse events as unfavorable or unintended
signs, symptoms or disease occurring after treatment that
are not necessarily related to the moxibustion interven-
tion. In every visit, adverse events will be reported by par-
ticipants and examined by the practitioner.
Ethics
Written consent will be obtained from each participant.
This study was approved by all relevant local ethics
review boards. Ethics Committee of Affiliated hospital of
Jiangxi Institute of Traditional Chinese Medicine had
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Discussions
To our knowledge, although there is no cure for KOA,
current kinds of therapies focus on the relief of pain and
stiffness and maintenance or improvement in functional
status and quality of life as important goals. A number of
clinical trial suggested moxibustion as one of traditional
acupuncture therapy, should effective in the treatment of
KOA. But the methodological problems of published tri-
als haunt us the trust of moxibustion. Therefore, we
design this rigorous clinical trials meeting the CONSORT
statement and guidelines to guarantee a high internal
validity for the results. In view of the special nature of the
KOA itself, positive control should be selected to solve
the patient's pain, swell, and impairment. At present, var-
ious conventional medications are used to slow down and
control with the disease. Although Anesthetic and
NSAIDS can relive the pain and inflammation, patients
are not considered it as priority options because of multi-
ple adverse reactions. Sodium Hyaluronate acid injec-
tions may give you more pain relief than oral medicines,
and less adverse reactions. Therefore, we used the
Sodium Hyaluronate acid injections as drug treatment in
the protocol.
Actually, the aim of this trial contains two parts: "Is
moxibustion treatment superior to Sodium Hyaluronate
acid injections for KOA? And is heat-sensitive moxibus-
tion superior to conventional moxibustion for KOA?" The
latter one is our more interesting goal. According to the
current theory of traditional Chinese medicine, moxibus-
tion resulting from the burning of moxa, produces the
radiant heat and drug effects to acupoints. This treatment
penetrates deeply into the body, restoring the balance and
flow of vital energy or life force through acupoints. So the
selected of location for manipulating Moxa plays an
important role in obtaining good effects. Generally
speaking, the location acupoints are fixed along meridi-
ans. The conventional moxibustion is promoted for
improving general health and treating diseases by stimu-
lating these fixed acupoints. And doctors consider hyper-
aemia due to local skin vasodilatation as the indicator of
moxibustion's effect. However, our clinical experience
and observation in the past suggested that stimulating
these fixed acupoints might not the best treatment site
for moxibustion. In the human being there are two func-
tional states, sensitization state and rest state. When the
human body has disease, acupoints on the body surface
may be sensitized with various types of sensitization, and
acupoint heat-sensitization is a type of acupoint sensiti-
zation. acupoint is more than fixed skin site but external
sensitive point reflecting the diseases. Therefore, acu-
point is variable and depends on the pathological state.
Traditional fixed acupints are thought as indicators to
searching specific sensitive acupoint. That is, traditional
fixed acupints don not consider the state as the key factor
to local the acupoint, so the course of fixing the position
is imprecisely.
When we light the moxa hold over the heat-sensitive
acupoints, the patients will produce some heat-sensitiza-
tion phenomenon. The following patients sensation will
suggest the special heat-sensitization aupoint: diather-
manous sensation due to moxa-heat, defining as the heat
sensation conducting from the moxa local skin surface
into deep tissue, or even into the joint cavity; expand heat
sensation due to moxa-heat, defining as the heat sensa-
tion spreading the surrounding little by little around the
moxa point; transfer heat sensation due to moxa-heat,
defining as the heat sensation transferring along some
pathway or direction, even to the ankle or hip conduc-
tion; non-heat sensation due to moxa-heat.
It is well-known that acupuncture and moxibustion
originated from China several thousands years ago. The
Inner Canon of Huangdi or Yellow Emperor's Inner
Canon is an ancient Chinese medical text that has been
treated as the fundamental doctrinal source for Chinese
medicine for more than two millennia and until today.
According with its core viewpoint and theory, acupoint is
described and understood with the state , which is certain
area of the skin in the course of diseases. "Said section
(acupoint) who shen-qi out of the procession itself, not
flesh bones "(Huang Di Neijing, Lingshu, Chapter: jiu
zhen shi er yuan).That is, acupoints are not flesh bones,
which have their particular morphology and fixed loca-
tion, but dynamic functional state due to shen-qi's activ-
ity. "when five internal organs are suffering from diseases,
we can use 12 yuan-acupoints to treat. These acupoints
are derived from five internal organs intrinsic nature. Five
internal organs are diagnosed by 12 yuan-acupoints. Dif-
ferent organs accord with relative yuan-acupoint. We can
observe and distinguish the acupoint response to external
stimulation. Then, the disease from five internal organs
can be diagnosed and treated by 12 yuan-acupoints"
(Huang Di Neijing, Lingshu, Chapter: jiu zhen shi er
yuan).So an important view was expressed by this sen-
tence, that is, acupoints reflect the internal diseases and
can be operated in treatment of disease with the func-
tional role. In physiological status, people do not always
become aware of the existence of acupoint. In contrast,
patients can feel some changes from acupoint involving
with diseases in pathological state. So the ancient persons
located the acupoints through the state changes. "Lung
shu-acupoints locate nearby the third vertebrae; Heart
shu-acupoints locate nearby the fifth vertebrae; Ge shu-
acupoints locate nearby the seventh; Liver shu-acupoints
locate nearby the ninth vertebrae; Spleen shu-acupoints
locate nearby the eleventh vertebrae; Kindey shu-acu-
points locate nearby the fourteenth vertebrae. These acu-
points are far from about three-inch by spinal crest. If you
want to search our acupoints exactly, the finger's touchChen et al. BMC Complementary and Alternative Medicine 2010, 10:32
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and press are must be use above the skin and we obtain the
sensation from patients, such as pain. " (Huang Di Nei-
jing, Lingshu, Chapter: back shu). Back shu acupoints are
searched by doctor through external stimulation. "If a
patient is coughing with shoulder, we can select the lat-
eral chest shu acupoints to treat. The shu acupoints are
nearby from the third vertebrae to the fifth vertebrae.
Press the location, patients will be comfortable at once.
Then we needle the location, which is acupoint actually."
(Huang Di Neijing, Lingshu, Chapter: five xie) We con-
clude that s e n s i t i z e d  s t a t u s  i s  k e y  f a c t o r  t o  l o c a t e  t h e
position of acupoints.
Among the changes, sensitized status is the common
one, described that acupoints on the body surface may be
sensitized with various types of sensitization. This sensi-
tized acupoint is not only the pathological phenomenon
reflecting the diseases but also stimulating location with
acupuncture and moxibustion. Acupoint heat-sensitiza-
t i o n  i s  a  t yp e  o f  a c u p o i n t  s e n s i t i za t i o n ,  w h i c h  d e r i v e d
from our clinical experience and research in past twenty
years. The special acupoint makes accordance with the
classical thought and theory from the Inner Canon of
Huangdi.
Our empirical evidence engaged us to formulate the
following hypothesis: selecting the heat-sensitized acu-
point may obtain therapeutic effect far better than acu-
puncture and moxibustion at acupoints of routine rest
state. The main aim of this trial is to test and verify the
hypothesis. If we can confirm this hypothesis, promoting
moxibustion clinical efficacy would be carried our in this
extraordinary way. It is of great significance to develop
the theory of acupuncture and moxibustion.
Therefore, the purpose of this trial is more than discuss
the efficacy of moxibustion as treatment. The results of
our trial will be helpful to supply the evidence on the
rules of heat-sensitive moxibustion location in China.
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